On Tuesday, Cogent Biosciences Inc (NASDAQ: COGT) opened higher 5.69% from the last session, before settling in for the closing price of $6.85. Price fluctuations for COGT have ranged from $5.73 to $12.61 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has dropped its sales by -33.00% annually for the last half of the decade. Company’s average yearly earnings per share was noted 9.37% at the time writing. With a float of $94.82 million, this company’s outstanding shares have now reached $110.46 million.
In an organization with 205 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Cogent Biosciences Inc (COGT) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Cogent Biosciences Inc is 16.72%, while institutional ownership is 91.79%. The most recent insider transaction that took place on Jan 14 ’25, was worth 332,412. In this transaction Chief Commercial Officer of this company bought 43,750 shares at a rate of $7.60, taking the stock ownership to the 45,848 shares.
Cogent Biosciences Inc (COGT) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.56 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 9.37% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 31.60% during the next five years compared to 10.02% growth over the previous five years of trading.
Cogent Biosciences Inc (NASDAQ: COGT) Trading Performance Indicators
Check out the current performance indicators for Cogent Biosciences Inc (COGT). In the past quarter, the stock posted a quick ratio of 5.32.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.47, a number that is poised to hit -0.58 in the next quarter and is forecasted to reach -1.87 in one year’s time.
Technical Analysis of Cogent Biosciences Inc (COGT)
Let’s dig in a bit further. During the last 5-days, its volume was 1.06 million. That was inferior than the volume of 1.44 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 38.95%. Additionally, its Average True Range was 0.54.
During the past 100 days, Cogent Biosciences Inc’s (COGT) raw stochastic average was set at 11.24%, which indicates a significant decrease from 40.72% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 79.87% in the past 14 days, which was higher than the 63.97% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $8.06, while its 200-day Moving Average is $9.26. However, in the short run, Cogent Biosciences Inc’s stock first resistance to watch stands at $7.48. Second resistance stands at $7.71. The third major resistance level sits at $8.15. If the price goes on to break the first support level at $6.81, it is likely to go to the next support level at $6.37. The third support level lies at $6.14 if the price breaches the second support level.
Cogent Biosciences Inc (NASDAQ: COGT) Key Stats
There are currently 113,850K shares outstanding in the company with a market cap of 824.27 million. Presently, the company’s annual sales total 0 K according to its annual income of -255,860 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -67,930 K.
